Sensex and Nifty erased all early gains and closed in the red following the Muhurat Trading session on Sunday, marking the first time the b...

HDFC Securities MD and CEO Dhiraj Relli identifies public sector banks, pharmaceuticals and defence as potential outperformers in Samvat 20...

Eight BSE 500 stocks more than doubled investors’ wealth since Diwali 2025, led by Aditya Infotech, HFCL and Welspun Corp. As Samvat 2083 b...

Jefferies CEO Rich Handler believes Indian equities remain reasonably valued despite the market correction and says easing long-term capita...

The Centre is weighing proposals to scrap or lower long-term capital gains tax and recalibrate securities transaction tax as it seeks to ad...

As US tariffs on Canadian kitchen cabinets are set to double to 50%, the industry faces significant challenges. Companies like Cabico are c...

Innovation-led investment opportunities in India are extending well beyond technology, with healthcare, auto components and industrials eme...

Commodity derivatives traders in India surged nearly 62% to 21 lakh in FY26, while equity F&O participants fell 20% to 85 lakh. Zerodha's N...

A company can report a loan, an advance, or an investment even after the cash has moved beyond its control. Sometimes the explanation is le...

European automakers have received a boost from recent earnings, but their recovery remains fragile. Rising competition from Chinese manufac...

Indian equities enter Samvat 2083 after a volatile year and a sharp market correction. While lower valuations have improved the risk-reward...

Nearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across ...

The Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...

India should examine trade margins across medicines, medical devices and consumables using a common, scientifically credible method - not a...

India’s smallcap sell-off is intensifying as margin trading facility (MTF) positions decline from record levels. With nearly Rs 72,000 cror...

Mahindra & Mahindra Financial Services shares fell sharply on despite a 55% year-on-year rise in Q2FY27 net profit to Rs 882 crore. Nomura ...

Sanofi Healthcare has obtained authorisation from the Central Drugs Standard Control Organisation for Qfitlia. This therapy is designed to ...